OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications
Qiong Li, Li Zhou, Siyuan Qin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115447-115447
Closed Access | Times Cited: 6
Qiong Li, Li Zhou, Siyuan Qin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115447-115447
Closed Access | Times Cited: 6
Showing 6 citing articles:
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 32
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 32
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Electronic and Steric Effects in a Gold(I)‐Catalyzed Intramolecular C(sp3)−H Bond Activation Reaction of 1‐Bromoalkynes
Rubén Miguélez, Omar Arto, Nina Semleit, et al.
Advanced Synthesis & Catalysis (2024) Vol. 366, Iss. 4, pp. 780-789
Open Access | Times Cited: 3
Rubén Miguélez, Omar Arto, Nina Semleit, et al.
Advanced Synthesis & Catalysis (2024) Vol. 366, Iss. 4, pp. 780-789
Open Access | Times Cited: 3
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Targeted degrader technologies as prospective SARS-CoV-2 therapies
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103847-103847
Closed Access | Times Cited: 2
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103847-103847
Closed Access | Times Cited: 2
PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications
Narayanaperumal Pravin, Krzysztof Jóźwiak
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116837-116837
Open Access
Narayanaperumal Pravin, Krzysztof Jóźwiak
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116837-116837
Open Access
